Mechanisms of <i>Artemisia scoparia</i>’s Anti‐Inflammatory Activity in Cultured Adipocytes, Macrophages, and Pancreatic β‐Cells

Abstract

SCO's ability to promote adipocyte development and function is thought to mediate its insulin-sensitizing actions in vivo. Our findings that SCO inhibits inflammatory responses through at least two distinct signaling pathways (ERK and NF-κB) in three cell types known to contribute to metabolic disease reveal that SCO may act more broadly than previously thought to improve metabolic health.